Company Filing History:
1 out of 5,076 
1 out of 132 
1 out of 1,743 
Years Active: 2012
Title: The Innovations of Anne-Laure Turcot-Dubois
Introduction
Anne-Laure Turcot-Dubois, an innovative inventor based in Nornaison, France, has made significant contributions to the field of pharmaceuticals. With a strong focus on the development of novel compounds, her work is not only groundbreaking but also holds promise for the future of cancer treatment.
Latest Patents
Anne-Laure holds a patent for a unique invention titled "α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them." This invention centers on the synthesis of α-galactoceramide analogs using unsaturated intermediate compounds, which allows for an efficient metathesis reaction. These analogs serve as active ingredients in pharmaceutical formulations, particularly those aimed at combating cancer.
Career Highlights
Throughout her career, Anne-Laure Turcot-Dubois has worked with esteemed institutions, notably the Centre National de la Recherche Scientifique and Université Paris Descartes. Her dedication to research and development has been pivotal in her patented inventions, highlighting her role in advancing medical science.
Collaborations
Anne-Laure’s research efforts have been enriched by her collaborations with notable colleagues, including Didier Dubreuil and Muriel Pipelier. These partnerships have fostered a productive environment for innovation and exploration in the field of pharmaceuticals.
Conclusion
In conclusion, Anne-Laure Turcot-Dubois stands out as a remarkable inventor whose work on α-galactoceramide analogs showcases the potential of innovative solutions in pharmaceuticals. Her contributions are paving the way for new treatments, particularly in the realm of cancer therapy, reflecting the profound impact of her inventions in today’s healthcare landscape.